
| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | 2026-03-24 | KILTS JAMES M | Director | Purchase | 31.0K | $0.79 | $25K | 1.60M | View ↗ | |
| 2026-03-20 | 2026-03-24 | KILTS JAMES M | Director | Purchase | 33.6K | $0.77 | $26K | 1.57M | View ↗ | |
| 2026-03-11 | 2026-03-13 | KILTS JAMES M | Director | Purchase | 16.8K | $0.70 | $12K | 1.53M | View ↗ | |
| 2026-03-10 | 2026-03-11 | KILTS JAMES M | Director | Purchase | 75.4K | $0.69 | $52K | 1.52M | View ↗ | |
| 2026-03-09 | 2026-03-11 | KILTS JAMES M | Director | Purchase | 66.5K | $0.61 | $41K | 1.44M | View ↗ |
No annual data found.
How The Story On Advanced Enzyme Technologies (NSEI:ADVENZYMES) Is Evolving Around A ₹370 Fair Value
Advantage Solutions Inc. 2026 Q1 - Results - Earnings Call Presentation
Earnings Update: Here's Why Analysts Just Lifted Their Advantage Solutions Inc. (NASDAQ:ADV) Price Target To US$42.50
Undervalued Small Caps With Insider Buying Opportunities In May 2026